当前位置: X-MOL 学术Amyloid › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The impact of Post-Transplant doxycycline in AL amyloidosis – updated results after Long-Term follow up
Amyloid ( IF 5.5 ) Pub Date : 2022-12-19 , DOI: 10.1080/13506129.2022.2155809
Nadine Abdallah 1 , Angela Dispenzieri 1 , Eli Muchtar 1 , Francis K Buadi 1 , Prashant Kapoor 1 , Martha Q Lacy 1 , Yi L Hwa 1 , Amie Fonder 1 , Miriam A Hobbs 1 , Suzanne R Hayman 1 , Nelson Leung 1, 2 , David Dingli 1 , Ronald S Go 1 , Yi Lin 1 , Wilson I Gonsalves 1 , Moritz Binder 1 , Taxiarchis Kourelis 1 , Rahma Warsame 1 , Robert A Kyle 1 , S Vincent Rajkumar 1 , Morie A Gertz 1 , Shaji K Kumar 1
Affiliation  

The current treatment paradigm of AL amyloidosis lacks effective fibril-directed therapies. Doxycycline has been shown to have anti-fibril properties in preclinical models. In 2012, we reported tha...

中文翻译:

移植后多西环素对 AL 淀粉样变性的影响——长期随访后的更新结果

目前 AL 淀粉样变性的治疗模式缺乏有效的原纤维定向疗法。多西环素已在临床前模型中显示出具有抗原纤维特性。2012 年,我们报道过...
更新日期:2022-12-19
down
wechat
bug